Evidence map›Paper›PMID 42059579›Full record

ArticleMicrobiology spectrum2026

Analytical comparison of over-the-counter multiplex tests for influenza A, influenza B, and SARS-CoV-2.

Sarah Lohsen, Yana Hoy-Schulz, Annie Taing, Beth Coughlin, Jordan Kim, Heather B Bowers, Julie Sullivan, Wilbur A Lam, Anuradha Rao, Sarah W Satola and 1 more

Abstract readComparative Study
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sarah Lohsen *Investigational Clinical Microbiology Core, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Yana Hoy-Schulz *Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.ORCID 0009-0005-7904-4122
Annie TaingInvestigational Clinical Microbiology Core, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Beth CoughlinInvestigational Clinical Microbiology Core, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Jordan KimInvestigational Clinical Microbiology Core, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Heather B BowersDepartment of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
Julie SullivanCenter for the Advancement of Diagnostics for a Just Society (ADJUST Center), Emory University, Atlanta, Georgia, USA.
Wilbur A LamCenter for the Advancement of Diagnostics for a Just Society (ADJUST Center), Emory University, Atlanta, Georgia, USA.
Anuradha RaoCenter for the Advancement of Diagnostics for a Just Society (ADJUST Center), Emory University, Atlanta, Georgia, USA.ORCID 0000-0001-6600-0677
Sarah W SatolaInvestigational Clinical Microbiology Core, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Gregory L DamhorstInvestigational Clinical Microbiology Core, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.ORCID 0000-0002-2237-1713

Funding

Flu Lab
6 · The paper itself

Abstract

Over-the-counter (OTC) lateral flow tests for respiratory viruses have newly emerged since the beginning of the coronavirus disease 2019 (COVID-19) pandemic and are increasingly available to consumers. While all marketed tests have met standards for Emergency Use Authorization (EUA), IMPORTANCE: Our study provides consumers and medical professionals alike with a head-to-head comparison of the available over-the-counter coronavirus disease (COVID)/flu rapid antigen tests through a controlled, systematic evaluation. We also highlight the observation that, at low viral concentrations, many of the tests converted from negative to positive during the designated "interpretation window," resulting in a practical recommendation that consumers should wait for the full incubation time before concluding that a self-test is negative.

Indexed as

COVID-19Influenza A virusInfluenza B virusInfluenza, HumanSARS-CoV-2HumansRapid Diagnostic TestsSensitivity and SpecificityinfluenzaSARS-CoV-2self-testing

Identifiers

PMID42059579
PMCPMC13228026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.